Article info
Original article
Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas
- Correspondence to Professor Hanlin L Wang, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA; HanlinWang{at}mednet.ucla.edu
Citation
Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas
Publication history
- Received December 22, 2015
- Revised April 1, 2016
- Accepted April 24, 2016
- First published May 11, 2016.
Online issue publication
November 18, 2016
Article Versions
- Previous version (11 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/